FLSM
ADVM

Frazier Life Sciences Management’s Adverum Biotechnologies ADVM Stock Holding History

Frazier Life Sciences Management’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,077,431
Closed -$9.41M – 41
2025
Q3 		$9.41M Buy
2,077,431
+1,008,187
+94% +$2.97M 0.28% 39
2025
Q2 		$2.3M Hold
1,069,244
– – 0.09% 48
2025
Q1 		$4.67M Hold
1,069,244
– – 0.21% 42
2024
Q4 		$4.99M Hold
1,069,244
– – 0.21% 47
2024
Q3 		$7.51M Hold
1,069,244
– – 0.3% 43
2024
Q2 		$7.34M Hold
1,069,244
– – 0.34% 42
2024
Q1 		$15.1M Buy
+1,069,244
New +$16.3M 0.64% 35

Frazier Life Sciences Management's ADVM Position: Q4 2025 in Review

Frazier Life Sciences Management sold out of Adverum Biotechnologies (ADVM) in Q4 2025, closing a stake of 2,077,431 shares — an estimated $9.41M sold.

Frazier Life Sciences Management first reported a position in ADVM in Q1 2024 and held it in 7 quarters. The position peaked at $15.1M in Q1 2024. 0 funds tracked by Wall St. Rank hold ADVM as of Q4 2025.

  • Frazier Life Sciences Management reported no remaining Adverum Biotechnologies position as of Q4 2025 after selling out during the quarter.
  • Frazier Life Sciences Management sold 2,077,431 Adverum Biotechnologies shares in Q4 2025, an estimated $9.41M.
  • Frazier Life Sciences Management first reported a position in Adverum Biotechnologies in Q1 2024 and held it in 7 quarters.
  • Frazier Life Sciences Management's Adverum Biotechnologies position peaked at $15.1M in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2025.

Based on Frazier Life Sciences Management's 13F filing for Q4 2025, filed 13 Feb 2026.